Literature DB >> 8908250

Localization of nitric oxide synthase I and III in the cochlea.

P Franz1, C Hauser-Kronberger, P Böck, C Quint, W D Baumgartner.   

Abstract

Nitric oxide synthase (NOS) isoforms I and III were localized in the guinea pig cochlea by indirect immunohistochemistry using frozen sections and paraffin sections. NOS I staining was observed in the cytoplasm of outer hair cells, in nerve cell somata and fibers of the spiral ganglion, and in axonal profiles of the spiral lamina next to the base of inner hair cells. In addition, lining cells of the inner sulcus and limbus, and cells of the spiral ligament stained for NOS I but vascular walls remained unstained. NOS III reactivity was seen in the cytoplasm of outer and inner hair cell, in lining cells of the limbus, and on the endolymphatic surface of marginal cells. Staining for NOS III of spiral ganglion perikarya showed varying intensity. Endothelial cells of cochlear glomeruli reacted for NOS III. NOS III in vascular endothelial cells implies regulatory effects of nitric oxide (NO) on vascular wall tonus and cochlear blood supply. NOS I in cochlear neurons indicates these cells as possible sources for NO during neuronal activity. Activated neurons may provide NO that adjusts cochlear perfusion to neuronal activity. Finally, NO that is liberated from hair cells or afferent synaptic terminals may act as an inhibitor on N-methyl-D-aspartate (NMDA) receptors (negative feed-back inhibition).

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8908250     DOI: 10.3109/00016489609137914

Source DB:  PubMed          Journal:  Acta Otolaryngol        ISSN: 0001-6489            Impact factor:   1.494


  9 in total

1.  Evidence for a possible NOS back-up system in the organ of Corti of the guinea pig.

Authors:  Ulf-Rüdiger Heinrich; Jan Maurer; Wolf Mann
Journal:  Eur Arch Otorhinolaryngol       Date:  2003-07-22       Impact factor: 2.503

Review 2.  [Possible molecular mechanisms of spontaneous remission in sudden idiopathic hearing loss].

Authors:  U-R Heinrich; J Brieger; R H Stauber; W J Mann
Journal:  HNO       Date:  2011-11       Impact factor: 1.284

3.  Endothelial nitric oxide synthase upregulation in the cochlea of the guinea pig after intratympanic gentamicin injection.

Authors:  Ulf-Rüdiger Heinrich; Oxana Selivanova; Jürgen Brieger; Wolf J Mann
Journal:  Eur Arch Otorhinolaryngol       Date:  2005-06-21       Impact factor: 2.503

4.  Role of nitric oxide on purinergic signalling in the cochlea.

Authors:  Narinobu Harada
Journal:  Purinergic Signal       Date:  2010-06-08       Impact factor: 3.765

5.  Ischemia-reperfusion injury of the cochlea: pharmacological strategies for cochlear protection and implications of glutamate and reactive oxygen species.

Authors:  Keiji Tabuchi; Bungo Nishimura; Shuho Tanaka; Kentaro Hayashi; Yuki Hirose; Akira Hara
Journal:  Curr Neuropharmacol       Date:  2010-06       Impact factor: 7.363

6.  Hyperbaric oxygen upregulates cochlear constitutive nitric oxide synthase.

Authors:  Chia-Der Lin; I-Hua Wei; Chih-Ho Lai; Te-Chun Hsia; Ming-Ching Kao; Ming-Hsui Tsai; Ching-Hsiang Wu; Mang-Hung Tsai
Journal:  BMC Neurosci       Date:  2011-02-22       Impact factor: 3.288

Review 7.  Diverse identities and sites of action of cochlear neurotransmitters.

Authors:  Siân R Kitcher; Alia M Pederson; Catherine J C Weisz
Journal:  Hear Res       Date:  2021-05-24       Impact factor: 3.672

8.  Characterization of transgenic mouse lines for labeling type I and type II afferent neurons in the cochlea.

Authors:  Pankhuri Vyas; Jingjing Sherry Wu; Adrian Jimenez; Elisabeth Glowatzki; Paul Albert Fuchs
Journal:  Sci Rep       Date:  2019-04-03       Impact factor: 4.379

9.  Experimental endolymphatic hydrops under action of a type II nitric oxide synthase inhibitor: otoacoustic emissions evaluation and electrocochleography.

Authors:  Claudio Marcio Yudi Ikino; Roseli Saraiva Moreira Bittar; Karina Midori Sato; Newton Macuco Capella
Journal:  Braz J Otorhinolaryngol       Date:  2006 Mar-Apr
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.